CLINICAL DIAGNOSTIC MARKET ANALYSIS

Clinical Diagnostic Market, By Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests), By Product (Instruments, Reagents, and Other Products), By End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-Care Testing, and Other End Users), and By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI5471
Pages :162
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Leading Companies

Companies covered:

Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Qiagen N.V, Hologic Inc., Siemens Healthineers AG, BioMerieux SA, Abbott Laboratories, Bio-Rad Laboratories Inc., Becton, Dickinson and Company, and Danaher Corporation (Beckman Coulter, Inc.), among others.

Global Clinical Diagnostic Market: Key Companies Insights

The global clinical diagnostic market is highly competitive. This is attributed to the rise in burden of infectious and chronic disease around the world, as a result, players in the market are focusing on launching novel diagnostic products in the market.

Some of the key players in the global clinical diagnostic market are Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Qiagen N.V, Hologic Inc., Siemens Healthineers AG, BioMerieux SA, Abbott Laboratories, Bio-Rad Laboratories Inc., Becton, Dickinson and Company, and Danaher Corporation (Beckman Coulter, Inc.), among others.